244
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Rho-kinase Inhibitors: Pharmacomodulations on the Lead Compound Y-32885

, , , , , & show all
Pages 381-390 | Published online: 30 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fabrizio Carta, Claudiu T Supuran & Andrea Scozzafava. (2012) Novel therapies for glaucoma: a patent review 2007 – 2011. Expert Opinion on Therapeutic Patents 22:1, pages 79-88.
Read now

Articles from other publishers (12)

Kinga Czarnota-Łydka, Katarzyna Kucwaj-Brysz, Patryk Pyka, Wawrzyniec Haberek, Sabina Podlewska & Jadwiga Handzlik. (2022) Multitargeting the Action of 5-HT6 Serotonin Receptor Ligands by Additional Modulation of Kinases in the Search for a New Therapy for Alzheimer’s Disease: Can It Work from a Molecular Point of View?. International Journal of Molecular Sciences 23:15, pages 8768.
Crossref
Vasudha Abbhi & Poonam Piplani. (2020) Rho-kinase (ROCK) Inhibitors - A Neuroprotective Therapeutic Paradigm with a Focus on Ocular Utility. Current Medicinal Chemistry 27:14, pages 2222-2256.
Crossref
Alain-Pierre Petit, Christel Garcia-Petit, Juan A. Bueren-Calabuig, Laurent M. Vuillard, Gilles Ferry & Jean A. Boutin. (2018) A structural study of the complex between neuroepithelial cell transforming gene 1 (Net1) and RhoA reveals a potential anticancer drug hot spot. Journal of Biological Chemistry 293:23, pages 9064-9077.
Crossref
Chuipu Cai, Qihui Wu, Yunxia Luo, Huili Ma, Jiangang Shen, Yongbin Zhang, Lei Yang, Yunbo Chen, Zehuai Wen & Qi Wang. (2017) In silico prediction of ROCK II inhibitors by different classification approaches. Molecular Diversity 21:4, pages 791-807.
Crossref
Aneta Gandalovičová, Daniel Rosel, Michael Fernandes, Pavel Veselý, Petr Heneberg, Vladimír Čermák, Luboš Petruželka, Sunil Kumar, Victoria Sanz-Moreno & Jan Brábek. (2017) Migrastatics—Anti-metastatic and Anti-invasion Drugs: Promises and Challenges. Trends in Cancer 3:6, pages 391-406.
Crossref
Surmil Shah & Jignasa Savjani. (2016) A review on ROCK-II inhibitors: From molecular modelling to synthesis. Bioorganic & Medicinal Chemistry Letters 26:10, pages 2383-2391.
Crossref
Yangbo Feng, Philip V. LoGrasso, Olivier Defert & Rongshi Li. (2015) Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential. Journal of Medicinal Chemistry 59:6, pages 2269-2300.
Crossref
Muriel Bonnet, Jack U. Flanagan, Denise A. Chan, Amato J. Giaccia & Michael P. Hay. (2014) Identifying novel targets in renal cell carcinoma: Design and synthesis of affinity chromatography reagents. Bioorganic & Medicinal Chemistry 22:2, pages 711-720.
Crossref
Jose L. Orgaz & Victoria Sanz-Moreno. (2013) Emerging molecular targets in melanoma invasion and metastasis. Pigment Cell & Melanoma Research 26:1, pages 39-57.
Crossref
Akitoshi Tsuno, Kaei Nasu, Yukie Kawano, Akitoshi Yuge, Haili Li, Wakana Abe & Hisashi Narahara. (2011) Fasudil Inhibits the Proliferation and Contractility and Induces Cell Cycle Arrest and Apoptosis of Human Endometriotic Stromal Cells: A Promising Agent for the Treatment of Endometriosis. The Journal of Clinical Endocrinology & Metabolism 96:12, pages E1944-E1952.
Crossref
Ming Dong, Bryan P. Yan, James K. Liao, Yat-Yin Lam, Gabriel W.K. Yip & Cheuk-Man Yu. (2010) Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases. Drug Discovery Today 15:15-16, pages 622-629.
Crossref
B Wojciak-Stothard. (2008) New drug targets for pulmonary hypertension: Rho GTPases in pulmonary vascular remodelling. Postgraduate Medical Journal 84:993, pages 348-353.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.